Combo Products Office Would Mitigate Cost Bias Under User-Fee System
This article was originally published in The Gray Sheet
Executive Summary
The creation of an FDA office for combination products would leave open the possibility that a user-fee structured review system could be managed without manufacturers given the option to request a particular center based on cost considerations.